Polycystic Ovarian Syndrome (PCOS) Competitive Landscape Report 2024: Out of 18 Drugs in the Pipeline for PCOS, Only 3 have Reached the Phase III Stage of Development
09 avr. 2024 10h50 HE
|
Research and Markets
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Polycystic Ovarian Syndrome (PCOS) - Competitive Landscape" report has been added to ResearchAndMarkets.com's offering. This report presents a...
Ovarian Cancer Opportunity Assessment Report 2024: A Blockbuster Market that is Expected to Grow from $3.3 Billion in 2022 to $4.1 Billion in 2032 with ImmunoGen, AstraZeneca, Merck, & GSK Dominating
09 avr. 2024 07h02 HE
|
Research and Markets
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Ovarian Cancer Opportunity Assessment and Forecast" report has been added to ResearchAndMarkets.com's offering.Ovarian Cancer is one of the most...
[Latest] Global Hereditary Cancer Testing Market Size/Share Worth USD 12.1 Billion by 2033 at a 7.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
02 avr. 2024 14h00 HE
|
Custom Market Insights
Austin, TX, USA, April 02, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Hereditary Cancer Testing Market Size, Trends and Insights By Disease Type...
[Latest] Global PARP Inhibitors Market Size/Share Worth USD 23.5 Billion by 2032 at a 12.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
27 mars 2024 14h30 HE
|
Custom Market Insights
Austin, TX, USA, March 28, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “PARP Inhibitors Market Size, Trends and Insights By Type (Olaparib, Rucaparib,...
Polycystic Ovary Syndrome (PCOS) Treatment Market Forecast: Projected Substantial Growth by 2031
25 janv. 2024 14h07 HE
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Polycystic Ovary Syndrome (PCOS) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology,...
Germ Cell Tumor Market revenue to hit USD 122 Billion by 2035, says Research Nester
21 nov. 2023 06h30 HE
|
Research Nester
New York, Nov. 21, 2023 (GLOBE NEWSWIRE) -- The global germ cell tumor market size is projected to grow at a CAGR of over 12% from 2024-2036. The market is expected to garner a revenue of USD 122...
Theratechnologies annonce l’administration du sudocétaxel zendusortide à la première patiente de l’essai clinique mis à jour sur le traitement du cancer de l’ovaire avancé
12 oct. 2023 07h30 HE
|
Theratechnologies
Un jalon pour le principal conjugué peptide-médicament de la Société après l’acceptation par la FDA, le 2 juin 2023, de la modification du protocole de l’étude de phase 1. MONTRÉAL, 12 oct....
Theratechnologies Announces Dosing of First Patient in Updated Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer
12 oct. 2023 07h30 HE
|
Theratechnologies
Milestone for Company’s lead peptide-drug conjugate candidate follows FDA acceptance of protocol amendment for Phase 1 study on June 2, 2023 MONTREAL, Oct. 12, 2023 (GLOBE NEWSWIRE) --...
Global Polycystic Ovary Syndrome (PCOS) Treatment Strategic Business Report 2023: Recent Advances in PCOS Management to Spur the Demand for PCOS Drugs
19 avr. 2023 09h23 HE
|
Research and Markets
Dublin, April 19, 2023 (GLOBE NEWSWIRE) -- The "Polycystic Ovary Syndrome (PCOS) Treatment: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global...
Outlook on the Premenstrual Syndrome Treatment Global Market to 2027: Increasing Prevalence of PMS and Premenstrual Dysphoric Disorder (PMDD) Across the World Drives Growth
23 févr. 2023 11h03 HE
|
Research and Markets
Dublin, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The "Premenstrual Syndrome Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...